v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2024 $ 1,157,847 $ 54 $ 4,515,879 $ (3,358,514) $ 428
Beginning balance, Shares at Dec. 31, 2024   542,549      
Exercise of stock options 11,182 $ 1 11,181    
Exercise of stock options, Shares   8,082      
Shares issued upon vesting of restricted stock units, value 20,127 $ 1 20,126    
Shares issued upon vesting of restricted stock units, shares   8,065      
Shares issued under At-The-Market Offering, net of issuance costs, value 907   907    
Shares issued under At-The-Market Offering, net of issuance costs, Shares   206      
Stock-based compensation 33,286   33,286    
Net loss (114,423)     (114,423)  
Unrealized loss on marketable securities (328)       (328)
Ending balance at Mar. 31, 2025 1,108,598 $ 56 4,581,379 (3,472,937) 100
Ending balance, Shares at Mar. 31, 2025   558,902      
Beginning balance at Dec. 31, 2025 1,168,973 $ 61 4,961,832 (3,793,564) 644
Beginning balance, Shares at Dec. 31, 2025   607,630      
Exercise of stock options 614   614    
Exercise of stock options, Shares   284      
Shares issued upon vesting of restricted stock units, value 16,528   16,528    
Shares issued upon vesting of restricted stock units, shares   7,199      
Stock-based compensation 25,379   25,379    
Net loss (100,799)     (100,799)  
Unrealized loss on marketable securities (1,028)       (1,028)
Ending balance at Mar. 31, 2026 $ 1,109,666 $ 61 $ 5,004,352 $ (3,894,363) $ (384)
Ending balance, Shares at Mar. 31, 2026   615,113